511 related articles for article (PubMed ID: 18171713)
1. Thioredoxin-interacting protein: a critical link between glucose toxicity and beta-cell apoptosis.
Chen J; Saxena G; Mungrue IN; Lusis AJ; Shalev A
Diabetes; 2008 Apr; 57(4):938-44. PubMed ID: 18171713
[TBL] [Abstract][Full Text] [Related]
2. Lack of TXNIP protects beta-cells against glucotoxicity.
Shalev A
Biochem Soc Trans; 2008 Oct; 36(Pt 5):963-5. PubMed ID: 18793170
[TBL] [Abstract][Full Text] [Related]
3. Insulin counteracts glucotoxic effects by suppressing thioredoxin-interacting protein production in INS-1E beta cells and in Psammomys obesus pancreatic islets.
Shaked M; Ketzinel-Gilad M; Ariav Y; Cerasi E; Kaiser N; Leibowitz G
Diabetologia; 2009 Apr; 52(4):636-44. PubMed ID: 19214472
[TBL] [Abstract][Full Text] [Related]
4. Lack of TXNIP protects against mitochondria-mediated apoptosis but not against fatty acid-induced ER stress-mediated beta-cell death.
Chen J; Fontes G; Saxena G; Poitout V; Shalev A
Diabetes; 2010 Feb; 59(2):440-7. PubMed ID: 19875615
[TBL] [Abstract][Full Text] [Related]
5. Thioredoxin-interacting protein is stimulated by glucose through a carbohydrate response element and induces beta-cell apoptosis.
Minn AH; Hafele C; Shalev A
Endocrinology; 2005 May; 146(5):2397-405. PubMed ID: 15705778
[TBL] [Abstract][Full Text] [Related]
6. High beta-cell mass prevents streptozotocin-induced diabetes in thioredoxin-interacting protein-deficient mice.
Masson E; Koren S; Razik F; Goldberg H; Kwan EP; Sheu L; Gaisano HY; Fantus IG
Am J Physiol Endocrinol Metab; 2009 Jun; 296(6):E1251-61. PubMed ID: 19223654
[TBL] [Abstract][Full Text] [Related]
7. SIRT6-mediated transcriptional suppression of Txnip is critical for pancreatic beta cell function and survival in mice.
Qin K; Zhang N; Zhang Z; Nipper M; Zhu Z; Leighton J; Xu K; Musi N; Wang P
Diabetologia; 2018 Apr; 61(4):906-918. PubMed ID: 29322219
[TBL] [Abstract][Full Text] [Related]
8. Thioredoxin-interacting protein deficiency induces Akt/Bcl-xL signaling and pancreatic beta-cell mass and protects against diabetes.
Chen J; Hui ST; Couto FM; Mungrue IN; Davis DB; Attie AD; Lusis AJ; Davis RA; Shalev A
FASEB J; 2008 Oct; 22(10):3581-94. PubMed ID: 18552236
[TBL] [Abstract][Full Text] [Related]
9. Diabetes induces and calcium channel blockers prevent cardiac expression of proapoptotic thioredoxin-interacting protein.
Chen J; Cha-Molstad H; Szabo A; Shalev A
Am J Physiol Endocrinol Metab; 2009 May; 296(5):E1133-9. PubMed ID: 19258488
[TBL] [Abstract][Full Text] [Related]
10. Preventing β-cell loss and diabetes with calcium channel blockers.
Xu G; Chen J; Jing G; Shalev A
Diabetes; 2012 Apr; 61(4):848-56. PubMed ID: 22442301
[TBL] [Abstract][Full Text] [Related]
11. Histone acetylation of glucose-induced thioredoxin-interacting protein gene expression in pancreatic islets.
Bompada P; Atac D; Luan C; Andersson R; Omella JD; Laakso EO; Wright J; Groop L; De Marinis Y
Int J Biochem Cell Biol; 2016 Dec; 81(Pt A):82-91. PubMed ID: 27989964
[TBL] [Abstract][Full Text] [Related]
12. W2476 ameliorates β-cell dysfunction and exerts therapeutic effects in mouse models of diabetes via modulation of the thioredoxin-interacting protein signaling pathway.
Li T; Lin GY; Zhong L; Zhou Y; Wang J; Zhu Y; Feng Y; Cai XQ; Liu Q; Nosjean O; Boutin JA; Renard P; Yang DH; Wang MW
Acta Pharmacol Sin; 2017 Jul; 38(7):1024-1037. PubMed ID: 28502980
[TBL] [Abstract][Full Text] [Related]
13. Exenatide inhibits beta-cell apoptosis by decreasing thioredoxin-interacting protein.
Chen J; Couto FM; Minn AH; Shalev A
Biochem Biophys Res Commun; 2006 Aug; 346(3):1067-74. PubMed ID: 16782054
[TBL] [Abstract][Full Text] [Related]
14. Palmitate and insulin counteract glucose-induced thioredoxin interacting protein (TXNIP) expression in insulin secreting cells via distinct mechanisms.
Panse M; Kluth O; Lorza-Gil E; Kaiser G; Mühlbauer E; Schürmann A; Häring HU; Ullrich S; Gerst F
PLoS One; 2018; 13(5):e0198016. PubMed ID: 29813102
[TBL] [Abstract][Full Text] [Related]
15. Mice lacking thioredoxin-interacting protein provide evidence linking cellular redox state to appropriate response to nutritional signals.
Hui TY; Sheth SS; Diffley JM; Potter DW; Lusis AJ; Attie AD; Davis RA
J Biol Chem; 2004 Jun; 279(23):24387-93. PubMed ID: 15047687
[TBL] [Abstract][Full Text] [Related]
16. Transcription factor Ets1 regulates expression of thioredoxin-interacting protein and inhibits insulin secretion in pancreatic β-cells.
Luo Y; He F; Hu L; Hai L; Huang M; Xu Z; Zhang J; Zhou Z; Liu F; Dai YS
PLoS One; 2014; 9(6):e99049. PubMed ID: 24897113
[TBL] [Abstract][Full Text] [Related]
17. Involvement of thioredoxin-interacting protein (TXNIP) in glucocorticoid-mediated beta cell death.
Reich E; Tamary A; Sionov RV; Melloul D
Diabetologia; 2012 Apr; 55(4):1048-57. PubMed ID: 22246375
[TBL] [Abstract][Full Text] [Related]
18. Possible role for the thioredoxin system in the protective effects of probucol in the pancreatic islets of diabetic rats.
Liu JH; Liu DF; Wang NN; Lin HL; Mei X
Clin Exp Pharmacol Physiol; 2011 Aug; 38(8):528-33. PubMed ID: 21615774
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-200 is induced by thioredoxin-interacting protein and regulates Zeb1 protein signaling and beta cell apoptosis.
Filios SR; Xu G; Chen J; Hong K; Jing G; Shalev A
J Biol Chem; 2014 Dec; 289(52):36275-83. PubMed ID: 25391656
[TBL] [Abstract][Full Text] [Related]
20. Cytokines Regulate β-Cell Thioredoxin-interacting Protein (TXNIP) via Distinct Mechanisms and Pathways.
Hong K; Xu G; Grayson TB; Shalev A
J Biol Chem; 2016 Apr; 291(16):8428-39. PubMed ID: 26858253
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
